Nutriband Receives Notice Of Allowance From USPTO For Commercial Brand Name Trademarks For Its Lead Product, Abuse-Deterrent Fentanyl Transdermal System
Benzinga Newsdesk 1 day ago
News
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Nutriband Inc. (NASDAQ:NTRB), a pharmaceutical company developing proprietary transdermal drug delivery systems, today announced that it has received a Notice of Allowance from the United States Patent and Trademark
Nutriband Inc. (NASDAQ:NTRB), a pharmaceutical company developing proprietary transdermal drug delivery systems, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO), dated November 3, 2026, for commercial brand name trademarks for its lead product, an abuse-deterrent fentanyl transdermal system. Nutriband intends to secure full trademark registration and intellectual property rights for its commercial brand names in the United States and internationally.
